by The Naked Emperor Masking is both a horrible, new normal phrase and a controversial topic. It was clear from quite early on that masks made little, if any difference, to the spread of Covid. However, the face nappies got politicised, resulting in strong opinions on every side. Even the behavioura
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ -
InMed Pharmaceuticals Inc. ( InMed or the Company ) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ( CBN ), today announced that executives of the Company will speak at the 2021
Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe ( CDP Europe ). CDP Europe will be held virtually from January 19-21, 2021. Michael Woudenberg - Vice President, Chemistry, Manufacturing & Controls, Karen Long - Senior Director, Drug Development, and Prof. Mauro Maccarrone PhD - Scientific Advisor to InMed will all be featured as expert speakers at the event.